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Summary
Bacterial pathogens deliver multiple effector pro-
teins into eukaryotic cells to subvert host cellular
processes and an emerging theme is the coopera-
tion between different effectors. Here, we reveal
that a ﬁne balance exists between effectors that
are delivered by enteropathogenic E. coli (EPEC)
which, if perturbed can have marked conse-
quences on the outcome of the infection. We show
that absence of the EPEC effector Tir confers onto
the bacterium a potent ability to destroy polarized
intestinal epithelia through extensive host cell
detachment. This process was dependent on the
EPEC effectors EspG and EspG2 through their
activation of the host cysteine protease calpain.
EspG and EspG2 are shown to activate calpain
during EPEC infection, which increases signiﬁ-
cantly in the absence of Tir – leading to rapid host
cell loss and necrosis. These ﬁndings reveal a new
function for EspG and EspG2 and show that Tir,
independent of its bacterial ligand Intimin, is
essential for maintaining the integrity of the epithe-
lium during EPEC infection by keeping the destruc-
tive activity of EspG and EspG2 in check.
Introduction
Many of the world’s most important diseases are caused
by bacterial pathogens that deliver multiple effector pro-
teins into eukaryotic host cells. Bacterial effector proteins
are an evolutionary diverse family with a wide range of
functions, enabling the bacterium to modulate many host
cellular processes. Typically, individual effector proteins
have a modular architecture with several functional
domains or motifs, which confer multiple functions onto
the effector. Emerging evidence suggests that effector
proteins can cooperate with each other inside the host cell
(Fu and Galan, 1999; McGhie et al., 2001; Kenny et al.,
2002; Dean et al., 2006; Cain et al., 2008), giving the
bacterial pathogen greater versatility in its ability to control
host cellular events.
Enteropathogenic E. coli (EPEC) is a bacterial pathogen
thatcausesseverewaterydiarrhoea,particularlyininfants,
and is responsible for a large proportion of infant deaths in
the developing world (Chen and Frankel, 2005). Following
ingestion, EPEC binds to the surface of the human small
intestine where it delivers multiple effector proteins into
small intestinal cells via a bacterial-encoded type III secre-
tionsystem(T3SS).Thebest-characterizedEPECeffector
proteins are encoded in a genomic pathogenicity island
called the locus of enterocyte effacement (LEE) which, in
addition to the T3SS genes, carries at least six effector
genes (map, espF, espG, espZ, tir, espH) and the eae
gene that encodes the outer membrane protein Intimin
(reviewed in Dean and Kenny, 2009). At least 14 effectors
locatedoutsidetheLEEregionhavebeenidentiﬁed(Iguchi
et al.,2009)althoughlittleisknownabouttheirfunction.Tir
is the best-studied EPEC effector and is inserted into the
host plasma membrane where it acts as a receptor for
Intimin, mediating intimate bacterial attachment to the host
cell (Kenny et al., 1997). Tir-Intimin interaction also
induces actin-polymerization to form an actin-rich ‘pedes-
tal’ beneath the bacterium. Several other Tir-dependent
signalling events have been reported that all depend on
Intimin (see Dean and Kenny, 2009). Other well-studied
EPEC effectors are Map and EspF, which possess several
overlapping functions as both disrupt tight junctions (TJs)
(McNamara et al., 2001; Dean and Kenny, 2004), target
mitochondria (Kenny and Jepson, 2000; Nougayrede and
Donnenberg,2004),effaceintestinalmicrovilli(Deanet al.,
2006) and inhibit the water transporter SGLT-1 (Dean
et al., 2006) with EspF, but not Map, inhibiting phagocyto-
sis (Quitard et al., 2006). In addition, Map has been shown
to induce ﬁlopodia formation (Kenny et al., 2002) and
promote cell invasion (Jepson et al., 2003) with the former
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cellular microbiologyevent regulated by Tir through its interaction with Intimin.
Much less is known about the functions of the other LEE
effectors although EspG and its non-LEE homologue
EspG2 (also known as Orf3) have been shown to play a
minor role in the disruption of epithelial barrier function
(Tomsonet al.,2005)andcausedisruptionofmicrotubules
(Matsuzawa et al., 2004; Shaw et al., 2005a). EPEC has
also been shown to cause an increase in levels of the
general host cysteine protease calpain (Potter et al., 2003;
Hardwidge et al., 2004), although the EPEC effectors that
mediate calpain upregulation have not been determined.
The calpains are a family of proteases that are found in
many tissue types, including the ubiquitously expressed
calpain I and II. Calpain cleaves a large number of host
proteins, particularly proteins involved in host focal adhe-
sions and cytoskeletal events and indeed calpain activity
has been linked to cell migration and cell detachment
(Glading et al., 2002).
It has long been established that EPEC can disrupt
epithelial barrier function (Canil et al., 1993) – an essen-
tial feature of the intestinal epithelium that is maintained
through apically located TJs between adjacent cells
(Schneeberger and Lynch, 2004). TJs create an effective
barrier to the movement of small molecules across the
epithelium and this can be measured as trans-epithelial
electrical resistance (TER). The disruption of TJs by
EPEC causes a loss of TER and is dependent on the
delivery of effector proteins into host cells (Guttman and
Finlay, 2009). Previous studies have shown that several
EPEC effectors contribute to epithelial barrier dysfunction
including Map and EspF (McNamara et al., 2001; Dean
and Kenny, 2004), with EspG and EspG2 playing a minor
role (Tomson et al., 2005). While the outer membrane
protein Intimin is essential for EPEC-mediated barrier dis-
ruption (Dean and Kenny, 2004), the contribution of its
primary receptor Tir is unclear with previous studies
reporting essential (Muza-Moons et al., 2003; Miyake
et al., 2005) or non-essential (Dean and Kenny, 2004)
roles. Recently, we deleted the map, espF, eae and tir
genes in all combinations and found that the barrier-
disrupting defects of all strains missing Map, EspF and/or
Intimin were reversed by deleting the tir gene (P. Dean
et al., unpublished). This supported previous ﬁndings that
the tir mutant does indeed disrupt barrier function and
also suggested that Tir possesses a novel role to prevent
undeﬁned effectors from causing barrier dysfunction.
Here, we show that disruption of epithelial barrier func-
tion by Tir-negative mutants involves an initial lag period,
which provides an explanation of why previous reports
have failed to observe the barrier-disrupting capacity of
the tir mutant. Moreover, we show that Tir plays a critical
role in maintaining the integrity of the epithelial mono-
layer as its absence promotes extensive detachment of
host cells. This destructive activity was shown to be
mediated by the redundant functions of two effectors –
EspG and EspG2 – linked to the activity of the general
host protease, calpain. EspG and EspG2 are shown to
activate calpain during normal EPEC infection but their
damaging effects on epithelial integrity are kept in-check
by the Tir effector protein. This work highlights the deli-
cate balance that has evolved between EPEC effectors
within host cells and uncovers new functions for Tir and
the EspG homologues.
Results
The tir mutant causes potent disruption of epithelial
barrier function, independent of Intimin
While our previous work revealed that tir–minus mutants
disrupt epithelial barrier function to a level observed with
wild-type(WT)EPEC,examinationofthekineticsrevealed
a subtle difference. Thus, while EPEC infection of TC-7
polarized epithelial cells led to a gradual loss in trans-
epithelial resistance (TER; a well-deﬁned indicator
of barrier disruption), a 1–2 h lag period consistently
occurred with the tir mutant before it induced a rapid
response (Fig. 1A).Asimilar result, whereby loss of barrier
function was preceded by a lag period with the tir mutant,
was also obtained with colonic T84 cells (not shown). As
previously reported (Dean and Kenny, 2004), mutants
missing a functional effector delivery system (espA strain)
or the Intimin outer membrane protein (eae strain) are
defective at causing barrier dysfunction and instead cause
a progressive increase in TER values (Fig. 1A). The TER
increase observed with these strains was due to increased
pH of the growth medium during bacterial infection (not
shown). Our studies routinely use a multiplicity of infection
(moi) of 200 bacteria per host cell (Dean and Kenny, 2004;
Dean et al., 2006), but much lower moi were used in
studiesreportingthatthetirmutantdoesnotdecreaseTER
(Muza-Moons et al., 2003; Miyake et al., 2005). We exam-
ined whether the discrepancy in data was related to the
differencesinmoibetweenthestudies.Arangeofmoiwere
tested (not shown) and an moi as high as 1:50 reproduced
the ﬁndings of other studies (Fig. 1B), with the tir mutant,
unlike the parental EPEC strain, failing to disrupt barrier
function over the examined 6–7 h infection period (Muza-
Moons et al., 2003; Miyake et al., 2005). By extending the
infection time to 11 h, the tir mutant induced a rapid loss in
barrier function after the lag, which occurred at a rate over
6 times faster (P < 0.0001) than the decrease with WT
EPEC (Fig. 1C), while a TER decrease was not observed
with the espA mutant over a similar 11 h infection period
(Fig. 1C). Thus, these data clearly demonstrate that the tir
mutant disrupts barrier function and shows that at lower
bacterial doses, the lag period associated with the tir
mutant persists for longer times, obscuring the strain’s
barrier-disrupting capacity.
EPEC effectors regulate calpain activity 1309
© 2010 Blackwell Publishing Ltd, Cellular Microbiology, 12, 1308–13210
50
100
150
200
250
300
0123456789 1 0 1 1
0
20
40
60
80
100
120
140
02468
0
50
100
150
200
250
02468
MOI 1:50
tir
WT
MOI 1:200
tir
WT
Infection time (h)
%
 
T
E
R
%
 
T
E
R
Infection time (h)
MOI 1:50
tir
WT
Infection time (h)
%
 
T
E
R
C
Infection time (h)
0
50
100
150
200
250
300
350
0123456
WT
espA
tir
eae
tir lag period
EPEC strains A
B
%
 
T
E
R
espA
Fig. 1. A lag phase persists in the disruption of barrier function by the tir mutant that is dictated by the multiplicity of infection (MOI).
A. Polarized intestinal cells were infected with the indicated EPEC strains and the transepithelial resistance (TER) was followed. The dotted
line indicates the lag period for the tir mutant where TER increases. The eae (Intimin) mutant cannot disrupt TER and was similar to that seen
with the espA mutant (which cannot deliver effectors into the host cell). Points represent mean  SEM, n = 3.
B. Polarized intestinal cells were infected with wild-type (WT) EPEC or the tir mutant at the moi indicated and the transepithelial resistance
(TER) was followed. The lag phase seen with the tir mutant at the moi of 1:200 (left) persisted to the end of the 7 h experiment at the moi of
1:50 (right).
C. Increased infection times with the moi of 1:50 shows the tir mutant can cause a rapid TER decrease. The rate of TER decrease for the tir
mutant following the lag period (35.11 h
-1  3.78 h
-1) was signiﬁcantly greater (P < 0.0001) than that of the WT (5.22 h
-1  1.52) while the
espA mutant displayed no TER decrease. Data points show mean  SEM, n = 3.
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during infection
Given the different kinetics of TER decrease between the
tir mutant and WT EPEC, we postulated that a different
mechanism of barrier dysfunction may be involved.
Microscopy analysis of infected cells revealed large voids
in tir-infected monolayers by 4 h post infection that was
suggestive of cell detachment (Fig. 2A) while WT EPEC-
infected monolayers remained relatively intact (Fig. 2A).
Indeed, by 7 h post infection, less than 20% of the mono-
layer remained attached following tir mutant infections,
unlike ~90% coverage for monolayers infected with WT
EPEC (Fig. 2B). Supporting these data, a corresponding
(~ﬁvefold) increase of cellular debris (measured by protein
determination) was evident in the supernatant of mono-
layers infected with the tir versus the WT EPEC strain
(Fig. 2C, P < 0.001), suggesting that the epithelium was
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Fig. 2. The absence of Tir causes a loss of epithelial monolayer integrity.
A. Microscopy of polarized intestinal cells stained with phalloidin following a 4 h infection with the tir mutant or wild-type (WT) EPEC shows
that tir-infected cells exhibit large cell-free voids in the monolayer, unlike that of WT. Percentage cell loss/unit area at 4 h post infection is
shown in the right graph.
B. Kinetics of cell loss during a 7 h infection with WT EPEC or the tir mutant for seven ﬁelds of view at ¥63 per experiment.
C. Cellular debris assessed by protein determination in the supernatant above the monolayer following a 6 h infection.
D. Level of necrosis in monolayers infected with indicated strains determined by trypan blue staining (6 ﬁelds of view at ¥40, n = 3).
E. Levels of apoptosis in monolayers after 6 h infection with indicated EPEC strains assessed by caspase-9 cleavage activity per mg protein.
Staurosporine (Stauro) was used as a positive control for apoptosis. For all graphs, data points represent mean  SEM, n = 3.
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Examination of host cell death prior to this extensive cell
loss (4 h post infection) revealed that WT EPEC infection
was linked to low levels of necrosis (assessed by trypan
blue) and apoptosis (assessed by caspase-9 cleavage).
However, the tir mutant infection resulted in a ~twofold
signiﬁcant increase in necrosis (Fig. 2D, P < 0.002)
without impacting on the low level of apoptosis (Fig. 2E,
P = 0.4). These data demonstrate that the rapid disruption
of epithelial barrier function observed with the tir mutant is
strongly correlated to detachment of host cells and linked
to a necrotic response, suggesting that the Tir effector
normally suppresses these events during EPEC infection.
Pre-delivery of Tir is protective against the destructive
activity of tir-deﬁcient strains
During EPEC infection, Map, EspF and Intimin (eae) col-
lectively mediate barrier dysfunction (Dean and Kenny,
2004) and as such a map/espF/eae triple mutant is unable
to disrupt TER (Fig. 3). However, we have found that a
quadruple mutant (deleted for these three genes and tir)
behaves like a tir mutant in that it causes rapid disruption
of TER after an initial lag period that is associated with cell
detachment (not shown; but see Fig. 3). This suggests
that in the absence of Tir, disruption of TER does not
require EPEC’s prominent barrier-disrupting proteins
Map, EspF or Intimin. Therefore, we utilized the map/
espF/eae triple mutant to pre-deliver Tir into host cells to
investigate whether Tir delivered by this strain would
prevent the quadruple mutant from decreasing TER. Epi-
thelial monolayers were infected for 1 h with the map/
espF/eae triple mutant or a strain (cfm-14; TTSS-) unable
to deliver Tir, after which the bacteria were killed with
antibiotics. Subsequent infection by the quadruple mutant
revealed that prior infection with the map/espF/eae strain
prevented barrier dysfunction while cfm-14 did not, sug-
gesting that pre-delivery of Tir was essential.
As it has been reported that infection of non-polarized
cells with effector-delivery competent strains inhibits the
delivery of effectors by subsequent infections (Mills et al.,
2008), we investigated whether our above ﬁndings were
due to a defect in effector delivery by the quadruple
mutant during the secondary infection. Detection of
similar amounts of EspF and EspB within cells (Fig. 3B)
pre-infected with the map/espF/eae followed by infection
with either WT EPEC or a map/eae/tir mutant conﬁrms
that the second wave of infections are not impeded in their
ability to deliver effector proteins. In addition, we found
that a secondary infection with WT EPEC following pre-
infection with the map/eae/tir triple mutant caused TER to
decrease (not shown), further supporting the premise that
effector delivery is not impeded in polarized cells. Taken
together, the data show that two-wave infections work
efficiently with polarized cells unlike that reported for non-
polarized cells. This validates our interpretation of the
above ﬁnding – that the rapid disruption of TER by the tir
mutant that is linked to cell detachment and necrosis can
be prevented by pre-delivery of Tir into host cells.
Barrier dysfunction by the tir mutant occurs
independently of actin rearrangements, unlike that of
wild-type EPEC
We previously noted that disruption of TER by EPEC can
be inhibited by pre-treating monolayers with the inhibitor
- -
-
+ map/espF/eae
cfm14 
+
+
-
+
+
+
+
+
+
+ First 
infection
Second 
infection
WT                
map/tir/eae - -
-
-
-
-
-
-
- -
-
-
-
-
-
-
-
-
Single 
infection
2-wave 
infection
Tir
EspB
EspF
Soluble host 
cell fraction
0
50
100
150
200
250
%
 
T
E
R
 
(
6
h
 
i
n
f
e
c
t
i
o
n
)
map/espF/eae First 
infection
Second 
infection
map/espF/eae/tir
+
+ +
+ +
cfm-14
+
+
-
- -
--
-
-
-
A
B
Fig. 3. Pre-delivery of Tir into host cells protects the epithelium
against the destructive activity of tir-minus mutants.
A. Transepithelial resistance (TER) of polarized intestinal cells after
6 h single- or co-infection with indicated strains. For co-infections,
monolayers were infected for 1 h with the triple map/espF/eae
mutant (to deliver Tir into host cells) or cfm-14 (a type three
secretion mutant that cannot deliver Tir), which were then killed
with antibiotics. Monolayers were then infected with the quadruple
map/espF/eae/tir mutant for 6 h. Data points represent
mean  SEM, n = 3.
B. Western blot of infected cell lysate from cells infected with ﬁrst
wave and second wave infections. Black arrow heads show that
the ﬁrst wave of infections does not affect the delivery of effectors
by the strains used in the second wave of infections. A map/tir/eae
triple mutant was used in place of the map/espF/eae/tir quadruple
mutant for the secondary infections to demonstrate that delivery of
EspF is unaffected and was similar to single- or co-infections with
WT EPEC.
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but see Fig. 4). As the kinetics of TER decrease for WT
EPEC and the tir mutant were different and were not
dependent on Map, EspF and Intimin in the latter strain,
we investigated whether the cellular mechanism was dif-
ferent for the two strains. Pre-treatment of cells with jas-
plakinolide prevented WT EPEC from decreasing TER
(P < 0.0001) but had little, if any impact on the ability of
the tir mutant to disrupt barrier function (P = 0.472; Fig. 4).
Similar results were obtained with the actin-destabilizing
agent cytochalasin D (not shown but see Fig. 6A). These
data suggest that barrier disruption by WT EPEC is
dependent on effector-driven actin rearrangements and
also demonstrates that a different cellular process, inde-
pendent of actin rearrangements, is responsible for TER
decrease seen with the tir mutant.
EspG and EspG2 mediate epithelial monolayer
destruction in the absence of Tir
The ability of the map/espF/eae/tir quadruple mutant to
cause detachment-linked TER decreases ruled out roles
for Map, EspF and Intimin in the process. To investigate
which effectors were involved, we examined the Dcore
mutant that is missing tir, map, espF and eae (Intimin)
genes and is also defective for the expression or secretion
of additional effectors including EspH, EspZ, NleH, NleF
and NleA (Ruchaud-Sparagano et al., 2007). The Dcore
mutant mimicked the tir mutant in its ability to cause
TER decrease (Fig. 5A, P = 0.7), suggesting the above
described effectors were not involved. By contrast, studies
with the espG/orf3/Dcore mutant (Ruchaud-Sparagano
et al., 2007) implicated a critical role for the EspG homo-
logues as this mutant was defective in causing a TER
decrease (Fig. 5A). Subsequent involvement of EspG and
EspG2 was supported by ﬁnding that anespG/orf3/tir triple
mutant failed to decrease TER (Fig. 5B) unless comple-
mented with plasmids encoding the espG or orf3 genes
(Fig. 5B). Interestingly, the inability of the espG/orf3/tir
triple mutant (which carries intact map, espF and eae
genes) to disrupt barrier function implicates a critical role
for Tir in the well-deﬁned Map/EspF/Intimin-dependent
barrier disruptive pathway (Dean and Kenny, 2004). This
premise was supported by restoring the strain’s barrier-
disruptingcapacitybyintroducingaTir-expressingplasmid
(Fig. 5B). Thus, the data show that Tir (independent of
Intimin) normally suppresses an EspG/EspG2 activity that
leads to loss ofTER by extensive cell detachment and also
demonstrates that Tir (along with Intimin) plays a key, but
previously cryptic, role in regulating the epithelial barrier
disrupting functions of Map and EspF.
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Fig. 5. EspG and EspG2 are responsible for the loss of epithelial
integrity caused by the absence of Tir. Transepithelial resistance
(TER) of polarized intestinal cells infected for 6 h with indicated
strains.
A. Deletion of espG and orf3 (encodes EspG2), but not other
effector genes prevents the TER decrease associated with the tir
mutant background. Dcore is unable to express or deliver the
effectors Map, EspF, Tir, EspH, EspZ, NleA, NleH1, NleH2 and also
absent for Intimin. espG/orf3/Dcore is absent for the effectors EspG
and EspG2 in the Dcore mutant background.
B. Complementation of the espG/orf3/tir triple mutant with plasmids
carrying either espG, orf3 (encodes EspG2) or tir. All infections
were performed at moi of 1:200. Results show mean  SEM,
n = 3.
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calpain inhibitors
A reported function of the EspG homologues is linked to
their destabilization of microtubules to release the RhoA-
speciﬁc GEF (GEF/H1) that activates the RhoA-Rock
signalling pathway to promote stress ﬁbre formation
(Matsuzawa et al., 2004). To investigate the role of this
pathway in the TER decrease caused by the tir mutant,
cells were pre-treated with the ROCK inhibitor Y27632.As
this treatment had no impact on the process (not shown;
but see below), we attempted to identify the signalling
pathway(s) mediating the EspG destructive effect. An
inhibitor screen was performed using a variety of broad
spectrum or speciﬁc inhibitors (Table 1) based on signal-
lingpathwaysimplicatedinEPECsubversiveevents.Con-
sistent with the ﬁnding using the ROCK inhibitor, taxol – a
microtubule stabilizing agent that prevents EspG-related
RhoA activation (Matsuzawa et al., 2004; Tomson et al.,
2005) – did not interfere with tir mutant TER decrease
(Fig. 6A, P = 0.7). Thus, this suggests that the EspG-
dependent activity linked to cell detachment is not related
to the destabilization of microtubules or the triggering of
the GEF/H1-RhoA-Rock signalling pathway. Strikingly,
only one of the 12 interrogated inhibitors (ALLN; a non-
speciﬁc cysteinyl protease inhibitor) prevented tir mutant-
mediated TER decreases (Fig. 6A, P < 0.003).As a target
of ALLN is ubiquitously expressed calpain–aC a 2+-
dependentproteasethatregulatescytoskeletalanchorage
complexes (Lebart and Benyamin, 2006) – we investi-
gated this linkage using two calpain inhibitors (calpeptin
and calpain inhibitor III). Both inhibitors were as effective
as ALLN in preventing tir mutant-associated TER
decreases (Fig. 6B), suggesting that calpain activity was
involved in theTER decrease linked to monolayer destruc-
tion by the tir mutant. This also suggested that EspG and
EspG2 may be activating calpain to cause host cell
detachment in the absence of Tir. Similar results, in which
EspG/Orf3 induce host cell detachment that is mediated
through a calpain dependent pathway, were also obtained
with HeLa cells (P. Dean et al., unpublished).
EspG and EspG2 over-activate host calpain activity in
the absence of Tir
To explore the hypothesis that the EspG homologues
promote calpain activation and that Tir may regulate this
event, we examined cellular calpain activity. These
studies used the synthetic calpain substrate Suc-LLVY-
AMC at 4 h post infection (i.e. prior to extensive cell loss;
Fig. 2). Figure 6C shows limited calpain activity in unin-
fected cells with the espA mutant causing a near-
signiﬁcant increase by 4 h post infection (P = 0.07; Fig. 1).
Interestingly, while WT EPEC infection signiﬁcantly
increased calpain activity relative to espA-infected cells
(P < 0.001), there was no signiﬁcant difference between
activity in espG/orf3- and espA-infected cells (P = 0.3). By
contrast, cells infected with the tir mutant exhibited a
signiﬁcant (~twofold) increase in calpain activity com-
pared with WT EPEC (P < 0.001; Fig. 6C). This clearly
shows that EPEC induce calpain activation in polarized
epithelial cells in a T3SS-dependent manner through the
effectors EspG and EspG2 and that this activation is
modulated by Tir.
As a previous report has shown an increase in calpain
in EPEC-infected cells (Hardwidge et al., 2004), we
examined the levels of calpain in infected host cells
to determine whether EspG/EspG2 induced a speciﬁc
upregulation of calpain. Although the levels of the calpain
I isoform were higher in the soluble and insoluble fractions
Table 1. Details of inhibitors used in the study.
Inhibitor
Working concentration
for polarized TC-7 cells Inhibitor site of action
Jasplakinolide 1 mM Inhibits F-actin depolymerization
Cytochalasin D 5 mM Inhibits F-actin polymerization
Wortmannin 1 mM PI 3-kinase inhibitor
Valinomycin 1 mM Disrupts mitochondrial membrane potential
AKT Inhibitor I 30 mM AKT Inhibitor
Genistein 300 mM Protein tyrosine kinase inhibitor
Go6976 5 mM PKC inhibitor
ALLN 10 mM Inhibits calpain I and II activity
ML-7 20 mM Myosin light chain kinase inhibitor
Taxol 50 mM Stabilizes microtubules
Staurosporine 1 mM Broad spectrum protein kinase inhibitor, induces apoptosis
Calpeptin 50 mM Inhibits calpain I and II activity
Calpain Inhibitor III 50 mM Inhibits calpain I and II activity
LY294 25 mM PI 3-kinase inhibitor
Y-27632 50 mM ROCK inhibitor
JAK inhibitor I 16 mM Inhibits Janus protein tyrosine kinases
Cyclohexamide 200 mgm l
-1 Inhibits protein translation
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(Fig. 6D), their levels were not signiﬁcantly different to the
TTSS- negative control (P = 0.2 and 0.31 respectively),
unlike the signiﬁcant difference shown in the calpain
activity assay (Fig. 6C). Similar results were obtained for
calpain II (ubiquitously expressed) and calpain V (found in
intestinal tissue) (not shown), suggesting that upregula-
tion of calpain levels in the tir mutant may not signiﬁcantly
contribute to the increased activation of calpain. Collec-
tively, this study demonstrates that EspG/EspG2 pro-
motes calpain activation during normal EPEC infection,
which is kept under tight control by Tir to limit the cell
detachment effects mediated by calpain.
Discussion
While it is well established that bacterial effectors
co-delivered into host cells can possess overlapping func-
tions, an emerging property is their ability to cooperate
with each other. Examples of this feature relate to effector-
driven cytoskeletal rearrangements that are downregu-
lated through the antagonistic action of co-delivered
effectors (Fu and Galan, 1999; Kenny et al., 2002; Cain
et al., 2008). However, these studies were performed on
cell types that lack several key features of cells that are
normally targeted by the bacteria in vivo. Here, we have
used a disease-relevant small intestinal model to show
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Fig. 6. EspG and EspG2 over-activate calpain in the tir mutant.
A. Inhibitor screening to identify the cellular pathway(s) involved in the potent tir mutant disruption of barrier function. Polarized intestinal cells
were infected for 5 h with the tir mutant and transepithelial resistance (TER) was recorded. ALLN, a calpain inhibitor was the only inhibitor in
this screen to signiﬁcantly prevent the TER decrease.
B. Two other calpain inhibitors calpeptin and calpain inhibitor III also prevented the TER decrease with the tir mutant.
C. Calpain activity in cells infected with various EPEC strains was measured by the release of AMC from the calpain substrate Suc-LLVY-AMC
per mg of cellular protein. All data points represent mean  SEM, n = 3.
D. Western blot of calpain I in host cells infected with the indicated strains. Calpain I bands were quantiﬁed by densitometry from three
separate experiments. Bars show mean  SEM.
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tease calpain through the cooperation of three of its effec-
tors to ensure that extensive detachment of host cells is
minimized during infection.
For over a decade it has been known that EPEC can
disrupt epithelial barrier function by a mechanism depen-
dent on the outer membrane protein Intimin (Canil et al.,
1993). Further studies have determined that the disruptive
process involves the activities of multiple effectors includ-
ing prominent roles for Map and EspF and minor roles for
the two EspG homologues (McNamara et al., 2001; Dean
and Kenny, 2004; Tomson et al., 2005). Unexpectedly,
a mutant missing the gene encoding the plasma
membrane-located Tir effector, which is the main receptor
for Intimin, was reported to be unable to disrupt barrier
function (Muza-Moons et al., 2003; Miyake et al., 2005),
while a separate study suggested otherwise (Dean and
Kenny, 2004). In this study, we resolve this discrepancy by
showing that although Tir has a critical role in EPEC’s
main barrier disrupting pathway (Map/EspF/Intimin-
mediated), its contribution until now was cryptic because
the absence of Tir leads to loss of barrier function by a
completely separate mechanism. We show that previous
studies which suggest that a tir mutant does not disrupt
barrier function (Muza-Moons et al., 2003; Miyake et al.,
2005) are due to modiﬁed infection protocols that resulted
in low moi that unknowingly extended a lag period asso-
ciated with the tir mutant, thereby obscuring the strain’s
barrier disrupting activity. These modiﬁed infection proto-
cols used an moi as low as 1:3 (Miyake et al., 2005) or
washed the epithelial cells after 1 h infection, thereby
artiﬁcially reducing the moi (Muza-Moons et al., 2003).
Our ﬁndings raise concerns on the interpretation of
studies (Muza-Moons et al., 2003; Miyake et al., 2005;
Tomson et al., 2005; Gill et al., 2007) with these modiﬁed
infection protocols using mutants that exhibit lag periods
in disrupting epithelial barrier function such as tir (this
study) and espG/orf3 mutants (Matsuzawa et al., 2005;
Tomson et al., 2005; P. Dean et al., unpublished).
In this study, we show that the main barrier-disrupting
proteins of EPEC are dependent on both Intimin and Tir to
induce barrier dysfunction. This premise was derived from
the ﬁnding that the espG/orf3/tir triple mutant is com-
pletely defective at causing a loss in TER much like the
eae mutant, despite the presence of EspF and Map in
these strains. This was further supported by ﬁnding that
the ability of the espG/orf3/tir mutant to disrupt TER is
restored when the strain is complemented with a Tir-
encoding plasmid. Previously, this crucial role of Tir in
barrier dysfunction was obscured in the single tir mutant
(Dean and Kenny, 2004) because of the unknown
destructive effects of EspG/G2 in this mutant background.
Taken together, this study shows that EPEC-mediated
barrier disruption requires Intimin (Canil et al., 1993; Dean
and Kenny, 2004), Tir (this study) and the cooperative
actions of Map and EspF (McNamara et al., 2001; Dean
and Kenny, 2004). The ﬁnding that cytoskeletal inhibitors
prevented WT EPEC but not the tir mutant from disrupting
barrier function suggested that the aforementioned
barrier-disrupting proteins function by altering the actin
cytoskeleton. This ﬁts well with the recently reported role
of Map as a guanine nucleotide-exchange factor for
Cdc42 – a regulator of cytoskeletal rearrangements
(Huang et al., 2009), EspF as a direct and indirect activa-
tor of N-WASP to induce actin nucleation (Alto et al.,
2007; Cheng et al., 2008; Peralta-Ramirez et al., 2008;
Sallee et al., 2008) and Tir/Intimin in inducing actin rear-
rangements (Kenny et al., 1997). While studies using
pharmacological agents have also implicated roles for
host kinases in barrier dysfunction (Guttman and Finlay,
2009), it is likely that these drugs act by preventing or
counter-acting cytoskeletal rearrangements triggered by
these effectors. Recently, another EPEC effector NleA
was reported to disrupt epithelial barrier function (Thana-
balasuriar et al., 2010) and the work presented here
suggests that NleA, like Map and EspF, cannot function
without Intimin or Tir being present as shown by the com-
plete defectiveness of the eae (Intimin) or espG/orf3/tir
mutants.
Tir’s role as a central regulatory effector must be given
serious consideration in light of past reports and the data
presented here. Tir has been shown to downregulate
Map-induced ﬁlopodia formation (Kenny et al., 2002),
modulate EspF’s ability to efface microvilli (P. Dean et al.,
unpublished), is implicated in NleA-mediated disruption of
barrier function (as described) and is shown to suppress
EspG/G2’s ability to activate calpain. Thus, in addition to
its crucial role in intimate attachment (Marches et al.,
2000), Tir appears to play an additionally important role in
regulating the functions of multiple effectors involved in
several patho-physiological events.
The tir mutant disrupted barrier function up to ~6 times
faster than the parental WT strain, suggesting that it
employed an alternative cellular mechanism. Although all
work in this study was performed with the Caco-2 derived
TC-7 cells, we found a similar result with colonic T84 cells
(not shown). Morphological and inhibitor data further sup-
ported the idea that the tir-negative mutant disrupts
barrier function by a distinct pathway. Thus, whereas
EPEC-mediated TER decreases are linked with TJ disas-
sembly (Simonovic et al., 2000; Dean and Kenny, 2004;
Guttman and Finlay, 2009), the tir mutant was linked with
extensive cell detachment with up to ~80% of the mono-
layer destroyed, compared with just ~10% for WT EPEC.
In addition, we found that the TJ complexes during tir
mutant infection were intact in the host cells that remain-
ing attached (not shown), unlike that with WT EPEC
(Dean and Kenny, 2004). Thus, cell detachment provided
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the tir mutant as monolayer conﬂuency is directly linked
with TER. The cellular mechanism that was responsible
for the destructive phenotype associated with the tir
mutant was dependent on the activation of host calpains
as the TER decrease caused by the tir mutant was (i)
prevented by inhibitors whose primary target are the Ca2+-
dependent calpains and (ii) calpain activity was signiﬁ-
cantly higher in the tir mutant infected cells. The ﬁnding
that the cell-detaching effects of the tir mutant were
dependent on EspG and EspG2 and that it correlated with
the increase in calpain activity, which was also dependent
on these two effectors, strongly supports the contention
that Tir acts to suppress EspG/EspG2-induced calpain
activity. Interestingly, the Tir-EspG/EspG2 calpain
pathway was not exclusive to polarized intestinal cells as
we found a similar ﬁnding with HeLa cells (not shown).
Recent structural data suggest that EspG family members
might act as a scaffold for a papain-like cysteine protease
with the N-terminus noted to be topologically similar to
cysteine protease inhibitors (Davis et al., 2008). This pro-
vides a mechanism whereby EspG may recruit activated
calpain but with speciﬁc calpain activity regulated through
EspG’s N-terminal domain, dependent on an unknown
function of Tir.
Previously, EPEC was reported to cause a threefold to
ﬁvefold increase in the levels of calpain in intestinal cells
(Hardwidge et al., 2004). We were unable to detect a
similar increase in protein levels for three common calpain
isoforms, although we did observe subtle differences
between the levels of calpain in cells infected with WT
EPEC, espG/orf3 and the tir mutant. However, our ﬁnding
that pre-treating host cells with cyclohexamide (which pre-
vents protein translation) did not compromise tir mutant
barrier disruption (not shown) suggests that the upregu-
lation of calpain levels is not essential for the tir mutant to
activate calpain. Further studies are underway to eluci-
date the mechanism by which Tir and EspG modulate
host calpain activity and the contribution of the different
calpain isoforms to the EPEC disease process.
Integrating the inhibitor, mutant and calpain activity
data with published work offers a model whereby EPEC
delivers the multi-functional EspG effectors to subvert
various cellular processes including microtubule destabi-
lization (Matsuzawa et al., 2005; Tomson et al., 2005),
stress ﬁbre formation (Matsuzawa et al., 2004), increas-
ing paracellular permeability (Matsuzawa et al., 2005;
Tomson et al., 2005), co-transporter inhibition (Gill et al.,
2007) and inducing calpain activation (this study). We
speculate that EPEC delivers sufficient levels of the
EspG/EspG2 to modulate these cellular processes with a
need for Tir to control or dampen the induction of calpain
activity to prevent cell detachment. Calpain cleaves a
number of host proteins, particularly those found in adhe-
sion complexes and their cleavage results in disassem-
bly of focal adhesions and cell rounding (Glading et al.,
2002; Franco and Huttenlocher, 2005), thus the linkage
between calpain and cell detachment is well established.
Prevention of host cell detachment and limiting cell turn-
over is an important strategy of bacterial pathogens
as host intestinal enterocytes are continually being
replaced, preventing many harmful invaders from becom-
ing established. Bacterial effector proteins have been
identiﬁed that inhibit host cell turnover, including Cif of
A/E pathogens, which blocks cell division (Marches
et al., 2003), or the recently reported Shigella effector
OspG, which prevents cell detachment by reinforcing
focal adhesions in polarized epithelial cells (Kim et al.,
2005). Our study suggests that the EPEC Tir can be
included into the family of effectors that inhibit cell
detachment.
What is the role of calpain activation during WT EPEC
infection? Although EPEC causes detachment of non-
polarized cells in a T3SS-dependent manner (Shifrin
et al., 2002), this is not a prominent feature associated
with EPEC-infected polarized epithelia, suggesting that
the small increases in calpain activity induced by EspG/
EspG2 in WT EPEC have other roles. It has been sug-
gested that calpain plays a role in microvilli effacement by
EPEC (Potter et al., 2003), but we and others ﬁnd no role
for EspG or EspG2 in effacement (P. Dean et al., unpub-
lished; Shaw et al., 2005b). Equally, calpain has been
implicated as a pro- and anti-apoptotic protein, but the low
level of apoptotic cells induced by EPEC was similar for
both the WT and the tir mutant. A more likely role relates
to the cleavage of tight junctional proteins such as occlu-
din (Zhu et al., 2006; Chun and Prince, 2009), which may
explain EspG’s reported role in selectively opening TJs to
small molecules (Matsuzawa et al., 2005). However, the
ﬁnding that Map and EspF cause a loss of the tight junc-
tional protein occludin in infected cells (Dean and Kenny,
2004) and that an espGorf3 double mutant causes signiﬁ-
cant tight junctional damage (Matsuzawa et al., 2005;
Tomson et al., 2005) implies that EPEC interaction with
TJs is a complex process with overlapping effector func-
tions. Whatever the role, it is clear that the cleavage of
host proteins by calpain is not very promiscuous during
EPEC infection but is under tight control as cell detach-
ment is not a common event, suggesting that the main
target of calpain, the adhesion complexes, remains rela-
tively intact during infection.
There is a growing consensus that interplay between
bacterial effector proteins is highly complex and well-
regulated process. While there are only a few examples of
regulatory mechanisms it is clear that the functions of
effectors do not proceed without restriction but are tight
controlled by the bacterium. This makes sense as most
effectors are multi-functional and have subtle effects on
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deleterious, loosening the pathogen’s grip on the host
cell. Future studies will determine the unanswered ques-
tions that remain including the nature of Tir suppressive
function on EspG/G2 activity, the mechanism of calpain
induction by EspG/G2 and the role that calpain activity
plays during EPEC infection.
Experimental procedures
Bacterial strains and plasmids
Enteropathogenic E. coli strains used in this study were WT
EPEC (E2348/69 O127:H6) (Levine et al., 1985), tir (Kenny et al.,
1997), espA (Kenny et al., 1996), espG/orf3 (Elliott et al., 2001),
cfm-14 (Donnenberg et al., 1990), the eae (Intimin) mutant
CVD206 (Donnenberg and Kaper, 1991), the quadruple mutant
map/espF/eae/tir (Quitard et al., 2006) and the espG/orf3/Dcore
mutant (Ruchaud-Sparagano et al., 2007). The Dcore mutant
was made as per the espG/orf3/Dcore mutant (Ruchaud-
Sparagano et al., 2007) using EPEC rather than the espG/orf3
double mutant as a recipient for allelic exchange. The map/espF/
eae triple mutant was generated via allelic exchange using the
suicide vector pCVD442 (Donnenberg and Kaper, 1991) as
described previously (Kenny et al., 1997). Brieﬂy, the map mutant
was used as a recipient for pCVD442-DespF to generate the
map/espF double mutant, which was used as a recipient for
pCVD442-Deae generating the map/espF/eae triple mutant. The
triple mutant espG/orf3/tir was made by allelic exchange using
the espG/orf3 mutant as a recipient for the suicide vector
pCVD442-Dtir. Disruption of targeted gene was veriﬁed by PCR
with Western blot analysis conﬁrming that the strain had a func-
tional T3SS and thus could deliver EspB into host cells. The
espG- (Matsuzawa et al., 2005) and tir-encoding (Kenny, 2001)
plasmids were selected with carbenicilin (100 mgm l
-1 ﬁnal con-
centration) or chloramphenicol (25 mgm l -1 ﬁnal concentration)
respectively.
Cell culture and infection assays
Bacterial culture and infection assays were as described previ-
ously (Dean and Kenny, 2004). The TC-7 cell line (Chantret et al.,
1994), a subclone of the heterogeneous intestinal cell line
Caco-2, was used for all assays in this study. TC-7 cells provide
a homogeneous population of enterocytes with a regular brush
border and rapid doubling time (Chantret et al., 1994). This well-
characterized cell line was used as it mimicked host–pathogen
events better than the parent Caco-2 cell line with less inherent
variability. TC-7 cells were used 12–15 days post conﬂuence and
cultured as previously described for Caco-2 cells (Dean and
Kenny, 2004) in transwells (Corning) on membrane ﬁlters with
0.4 mM sized pore. Infection assays were performed as previ-
ously reported for Caco-2 (Dean and Kenny, 2004). Brieﬂy, the
OD600 of overnight bacterial cultures was measured and suspen-
sions were diluted in Dulbecco’s modiﬁed Eagle’s medium
(DMEM) and grown in this medium (at 37°C in 5% CO2)f o r3h .
The OD600 of the suspensions was measured and diluted accord-
ingly to the indicated moi (typically 1:200 for most experiments)
and added to the apical surface of TC-7 monolayers on mem-
brane ﬁlters. TER was measured at selected time points as
previously described (Dean and Kenny, 2004) with the TER
values for the TC-7 cell line consistently between 200 and
300 W cm-2. The term TER corresponds to the electrical resis-
tance of the epithelium plus that of the membrane ﬁlter and
solutions with TER ﬂuctuation not providing mechanistic insight
on the nature of any change.
Western blot
Infected cells were washed twice in PBS and lysed in 1% (v/v)
Triton-X 100 for 5 min prior to centrifugation at 12 000 g. The
‘soluble’ supernatant containing the cytoplasmic and membrane
fractions was removed and the ‘insoluble’ cell pellet was washed
in PBS. Both fractions were subject to SDS-PAGE and Western
blot as described (Dean and Kenny, 2004). Antibodies used were
calpain-m (Sigma), calpain-V (Biovision), calpain-I (Chemicon)
and actin (Sigma). To quantify the intensity of the bands, densi-
tometrical analysis from at three separate blots was performed
using the software program Image J.
Two-wave infections
TC-7 cells (12–15 days post conﬂuence) were left uninfected or
infected 1 h with the map/espF/eae or cfm-14 mutants (moi was
1:200). After infection the cells were washed three times in
DMEM and the bacteria killed (gentamycin 100 mgm l
-1 and
penicillin/streptomycin 100 units ml
-1 ﬁnal concentration in
DMEM for 30 min). Cells were washed 3 times in DMEM and
incubated with indicated strains using the normal infection proto-
col with TER monitored for a further 6 h.
Cell death and detachment assays
The level of infection-induced cell detachment was determined by
centrifuging host cells within the supernatant at 500 g for 10 min,
with two separate PBS washes. This isolated the majority of host
cells away from the bacteria, which remained in the supernatant.
The cell pellet was lysed with 0.1 M NaOH in PBS and the protein
content determined using Bradford reagent (Sigma) assaying at
495 nm. The level of cell necrosis of infected monolayers was
determined by incubating with 0.2% (w/v) trypan blue in PBS for
5 min, washing in PBS and visualizing cells using a conventional
light microscope. The number of blue cells was recorded per ﬁeld
of view using a ¥40 objective lens examining six ﬁelds of view per
experiment. The level of apoptosis was determined by assaying
caspase-9 cleavage using the substrate LEHD-pNA. The libera-
tion of pNA was detected spectrophotometry at 405 nm accord-
ing to manufacturer’s instructions (Calbiochem 218824). As a
positive control, cells were incubated in DMEM containing stau-
rosporine (1 mM) to induce apoptosis (Bertrand et al., 1994).
Confocal microscopy
At select times post infection, the TC-7 monolayers were washed
gently in PBS and ﬁxed in 2.5% (w/v) paraformaldehyde for
15 min. Cells were then washed and incubated in a solution of
phalloidin to stain F-actin as previously described (Dean and
Kenny, 2004). Cells were visualized using a Leica SP2 confocal
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z-axis and reconstructing the monolayer as a composite projec-
tion. The level of cell detachment was determined using Leica
confocal software by calculating the area of cell-free voids as
regions of interests in the ﬁeld of view and expressing as a
percentage of the total ﬁeld.
Inhibitor assays
All inhibitors were added to the apical and basal wells of polarized
TC-7 cells (12–15 days post conﬂuent) for 2 h prior to infection
then removed from the apical well (2 washes in DMEM) prior to
the addition of bacteria. Bacterial infection and TER monitoring
were performed as above. Although the TC-7 cells were washed
prior to infection, each inhibitor was assessed for its effect on
bacterial growth at the concentration used. No inhibitor used in
this study affected bacterial growth in DMEM over the time-
course of the experiment (not shown). Working concentrations of
inhibitors used in this study and their mode of action is given in
Table 1. All inhibitors were purchased from Calbiochem except
valinomycin and wortmannin, which were from Sigma.
Calpain activity
Measurement of calpain activity was performed based on the
catalytic cleavage of the synthetic calpain substrate Suc-LLVY-
AMC in the presence of Ca
2+ and the reducing agent TCEP. The
liberation of AMC during the reaction was detected at a wave-
length of 460 nm. AMC (mM) released was determined using an
AMC standard curve. Following infection, TC-7 cells were har-
vested and washed with PBS, lysed in Cytobuster (Calbiochem)
and incubated on ice for 30 min. The lysate was centrifuged at
4°C at 12 000 g and the protein content was determined using
BCA reagent. Calpain activity was determined using Suc-LLVY-
AMC with the calpain activity kit according to the manufacturer’s
instructions (Calbiochem).
Statistical analysis
Signiﬁcance levels within data sets were determined using a
one-way ANOVA with a post hoc Tukey test indicating signiﬁcan-
ces between individual data points.
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